Indaptus Therapeutics, Inc. financial data

Symbol
INDP on Nasdaq
Industry
Pharmaceutical Preparations
Location
3 Columbus Circle, 15 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Intec Parent Inc. (to 8/3/2021)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 465 % -47.5%
Debt-to-equity 25.7 % +103%
Return On Equity -177 % -135%
Return On Assets -141 % -110%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.2M shares +21.4%
Common Stock, Shares, Outstanding 10.2M shares +21.4%
Entity Public Float 13.3M USD -11.9%
Common Stock, Value, Issued 102K USD +21.4%
Weighted Average Number of Shares Outstanding, Basic 9.51M shares +13.2%
Weighted Average Number of Shares Outstanding, Diluted 9.51M shares +13.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6.81M USD -9.24%
General and Administrative Expense 8.57M USD -2.49%
Operating Income (Loss) -15.4M USD +5.6%
Nonoperating Income (Expense) 480K USD -60.3%
Net Income (Loss) Attributable to Parent -14.9M USD +1.21%
Earnings Per Share, Basic -1.7 USD/shares +6.08%
Earnings Per Share, Diluted -1.7 USD/shares +31.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.38M USD -53.8%
Marketable Securities, Current 6.99M USD -62.7%
Assets, Current 7.63M USD -54.7%
Property, Plant and Equipment, Net 735 USD -63.6%
Operating Lease, Right-of-Use Asset 106K USD -45.7%
Other Assets, Noncurrent 505K USD -33.1%
Assets 8.24M USD -53.7%
Accounts Payable, Current 556K USD -9.93%
Employee-related Liabilities, Current 940K USD +18.2%
Liabilities, Current 2.23M USD -5.61%
Operating Lease, Liability, Noncurrent 4.01K USD -95.8%
Liabilities 2.24M USD -9.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 134K USD
Retained Earnings (Accumulated Deficit) -56.3M USD -36%
Stockholders' Equity Attributable to Parent 6M USD -60.8%
Liabilities and Equity 8.24M USD -53.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.94M USD +20.7%
Net Cash Provided by (Used in) Financing Activities 316K USD
Net Cash Provided by (Used in) Investing Activities 2.14M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 10.2M shares +21.4%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 54.5M USD +4.83%
Deferred Tax Assets, Gross 54.5M USD +4.86%
Operating Lease, Liability 108K USD -45%
Depreciation 735 USD +129%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -14.9M USD +1.31%
Lessee, Operating Lease, Liability, to be Paid 113K USD -47.3%
Operating Lease, Liability, Current 104K USD +2.95%
Lessee, Operating Lease, Liability, to be Paid, Year Two 86.9K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 86.9K USD -14.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.68K USD -73.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 86.9K USD
Deferred Tax Assets, Operating Loss Carryforwards 51.8M USD +3.19%
Operating Lease, Payments 25.3K USD +2.36%
Additional Paid in Capital 62.2M USD +9.79%